Horizon 2020
The EU Framework Programme for Research and Innovation

Navigation path

Health, Demographic Change and Wellbeing

Article
Responding to this challenge, research and innovation (R&I) under Horizon 2020 is an investment in better health for all. It aims to keep older people active and independent for longer and supports the development of new, safer and more effective interventions. R&I under Horizon 2020 also contributes to the sustainability of health and care systems.

During the first two years of Horizon 2020 (Work Programme for 2014/15), the EU will invest some €1 200 million in this Challenge.

Personalising health and care

Research & Innovation supported by this call will:

  • improve our understanding of the causes and mechanisms underlying health, healthy ageing and disease;
  • improve our ability to monitor health and to prevent, detect, treat and manage disease;
  • support older persons to remain active and healthy;
  • and test and demonstrate new models and tools for health and care delivery.

Coordination activities

R&I supported by this call will leverage Member State activities in areas including neuroscience, cancer, systems medicine. It will contribute to European and international initiatives such as the European Innovation Partnership on Active and Healthy Ageing, the Global Alliance for Chronic Diseases, the Joint Programming Initiative "More Years, Better Lives - the Challenges and Opportunities of Demographic Change" and the Joint Programming on Neurodegenerative Diseases Research.

Other activities

Several activities not included in the 2014/15 work programme will also be part of the 'Health, demographic change and wellbeing' challenge, notably the Innovative Medicines Initiative, the European and Developing Countries Clinical Trials Partnership (EDCTP), and the Active and Assisted Living Programme.

Scientific Panel for Health

The Scientific Panel for Health is a science-led expert panel, whose role will be to:

  • analyse and propose solutions to bottlenecks that prevent improvements in health
  • identify long term trends influencing health through foresight and recommend research and innovation priorities to respond to them
  • aid in the translation and implementation of research and innovation results into practice

Horizon Prize for better use of antibiotics

antibiotics prize bannerThis €1 million challenge prize addresses the issue of the unnecessary use of antibiotics, which is contributing to the growing problem of antibiotic resistance. The challenge is to develop a rapid test that will allow healthcare providers to distinguish at the point of care between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics.

R&I performers

R&I supported by this societal challenge will enable the translation of findings from the laboratory into the clinic and other health and care settings, by engaging all relevant R&I performers. For instance,

Newsroom

Calls

Deadline: 15/04/2015 - 02:00
Deadline: 21/04/2015 - 02:00
Deadline: 21/04/2015 - 02:00

Events

From 15/06/2015 - 02:00 to 17/06/2015 - 02:00
Riga, Latvia,

First Innovative Enterprise week “Access to Finance for Research, Innovation and SMEs 2015” is a 3-day international conference on:

  • the political answer to the macroeconomic situation
  • ways to boost growth, jobs and competitiveness through innovation, including the investment Plan for the EU
  • how the financial instruments, facilities and accompanying measures launched under Horizon 2020 can enhance access to finance for research, innovation and SMEs
Read more

From 10/03/2015 - 01:00 to 11/03/2015 - 01:00
Brussels, Belgium,

Horizon 2020 has started, a new game with new rules. What are the experiences so far? What has improved? What new obstacles and challenges have appeared? Are there already best practices we can learn from? Read more

From 09/03/2015 - 01:00 to 10/03/2015 - 01:00
Brussels,

The Summit on Innovation for Active and Healthy Ageing aims to engage Europe's policy, services and market leaders to co-create a shared vision on how Europe can address the challenges and seize the opportunities arising from demographic change through ICT and innovation and in that way contribute to economic recovery. Read more

Multimedia

20/06/2014 - 12:13

In 30 years’ time, there will be 150 million older people living in the EU. Where will you live? What kind of shape will you be in? Will you still be healthy and independent? Society is ageing. But making sure our golden years are happier and healthier is not just down to the individual, it’s also down to the whole society, public and private sectors together. Improving the quality of life of older people is a priority for the European Commission. Read more

19/11/2013 - 15:33

The goal of the Human Brain Project is to build a completely new information computing technology infrastructure for neuroscience and for brain-related research in medicine and computing, catalysing a global collaborative effort to understand the human brain and its diseases and ultimately to emulate its computational capabilities.

Read more

04/12/2013 - 12:22

Coralie Chanvillard is an early stage researcher undertaking a PhD in Berlin, under the ITN Grant of the Marie Skłodowska-Curie programme. This grant gave her the opportunity to gain plenty of scientific experience and to do part of her research in other European Union Member States. She is researching her PhD in Immunology in Berlin at the Hospital Charité. Her research is on multiple sclerosis. Read more

News

02/03/2015 - 19:04

The European Union has been active in the response to the Ebola emergency from the start. Ahead of the high-level conference on Ebola taking place in Brussels on 3 March, the European Commission has published a state of play of its actions. The EU's total financial contribution to fight the epidemic is over €1.2 billion. Read more

24/02/2015 - 17:06

The fight against Ebola has moved one step closer to an effective treatment against the disease. Thanks to EU funding from the Horizon 2020 research and innovation programme, the French National Institute of Health and Medical Research (INSERM) last night announced encouraging evidence that the antiviral drug favipiravir might be an effective treatment against early Ebola disease. Read more

26/09/2014 - 14:50

The International Journal of Social Robotics has issued a Call for Papers for its forthcoming Special Issue on New Frontiers of Service Robotics for Active and Healthy Ageing. Read more

Project stories

27/02/2015 - 17:17

If you are at risk of developing diabetes, it will come as no surprise if your doctor suggests you keep an eye on your weight and step up your physical activity. A number of lifestyle aspects are known to play a role. Other insights are only just emerging: new EU-funded research highlights the importance of living in sync with your body clock. Read more

27/02/2015 - 01:00

Luckily, sarcomas are rare – but this also means that very few clinical trials have investigated better ways to tackle these malignant tumours. The fact that there are many types of sarcoma, which respond to treatment in very different ways, adds to the difficulty of organising such studies. An EU-funded cancer research project has taken up the challenge in a bid to develop targeted treatments. Read more

25/02/2015 - 18:11

Roughly 3 000 pharmaceutical products are used in human healthcare. Since a patient’s body does not fully metabolise some of them, they are excreted and can end up in the environment, where they can impact aquatic life, and potentially human beings. EU-funded researchers investigated how much concern is warranted about anticancer drugs and antibiotics. Read more

Press Release

16/01/2015 - 15:55

The European Commission is today announcing eight research projects into Ebola that will be funded with a total of €215 million. These projects will develop vaccines and rapid diagnostic tests, which are key to overcoming the current Ebola crisis.
The projects are run under the new Ebola+ programme of the Innovative Medicines Initiative (IMI) and funded jointly by the European Commission and the European pharmaceutical industry. Read more

Latest open calls

(ordered by closing date)

@EU_eHealth